Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Lung Cancer Screening Market and Volume Analysis

5.1 Market
5.2 Volume


6. Market Share - Global Lung Cancer Screening

6.1 By Cancer Type
6.2 By End User
6.3 By Country


7. Cancer Type -Global Lung Cancer Screening Market

7.1 Non-Small-cell Lung Cancer (NSCLC)
7.2 Small-cell Lung Cancer


8. End User - Global Lung Cancer Screening Market

8.1 Hospitals & Clinics
8.2 Diagnostic Centers
8.3 Research Institute
8.4 Others


9. North America – Lung Cancer Statistics

9.1 United States

9.1.1 Lung Cancer Screening Market
9.1.2 Lung Cancer Screening Numbers
9.1.3 Lung Cancer Cases
9.1.4 Lung Cancer Deaths

9.2 Canada

9.2.1 Lung Cancer Screening Market
9.2.2 Lung Cancer Screening Numbers
9.2.3 Lung Cancer Cases
9.2.4 Lung Cancer Deaths

9.3 Mexico

9.3.1 Lung Cancer Screening Market
9.3.2 Lung Cancer Screening Numbers
9.3.3 Lung Cancer Cases
9.3.4 Lung Cancer Deaths


10. Europe – Lung Cancer Statistics

10.1 Germany

10.1.1 Lung Cancer Screening Market
10.1.2 Lung Cancer Screening Numbers
10.1.3 Lung Cancer Cases
10.1.4 Lung Cancer Deaths

10.2 United Kingdom

10.2.1 Lung Cancer Screening Market
10.2.2 Lung Cancer Screening Numbers
10.2.3 Lung Cancer Cases
10.2.4 Lung Cancer Deaths

10.3 France

10.3.1 Lung Cancer Screening Market
10.3.2 Lung Cancer Screening Numbers
10.3.3 Lung Cancer Cases
10.3.4 Lung Cancer Deaths

10.4 Italy

10.4.1 Lung Cancer Screening Market
10.4.2 Lung Cancer Screening Numbers
10.4.3 Lung Cancer Cases
10.4.4 Lung Cancer Deaths

10.5 Spain

10.5.1 Lung Cancer Screening Market
10.5.2 Lung Cancer Screening Numbers
10.5.3 Lung Cancer Cases
10.5.4 Lung Cancer Deaths

10.6 Netherlands

10.6.1 Lung Cancer Screening Market
10.6.2 Lung Cancer Screening Numbers
10.6.3 Lung Cancer Cases
10.6.4 Lung Cancer Deaths

10.7 Switzerland

10.7.1 Lung Cancer Screening Market
10.7.2 Lung Cancer Screening Numbers
10.7.3 Lung Cancer Cases
10.7.4 Lung Cancer Deaths


11. Asia – Lung Cancer Statistics

11.1 China

11.1.1 Lung Cancer Screening Market
11.1.2 Lung Cancer Screening Numbers
11.1.3 Lung Cancer Cases
11.1.4 Lung Cancer Deaths

11.2 Japan

11.2.1 Lung Cancer Screening Market
11.2.2 Lung Cancer Screening Numbers
11.2.3 Lung Cancer Cases
11.2.4 Lung Cancer Deaths

11.3 India

11.3.1 Lung Cancer Screening Market
11.3.2 Lung Cancer Screening Numbers
11.3.3 Lung Cancer Cases
11.3.4 Lung Cancer Deaths

11.4 South Korea

11.4.1 Lung Cancer Screening Market
11.4.2 Lung Cancer Screening Numbers
11.4.3 Lung Cancer Cases
11.4.4 Lung Cancer Deaths

11.5 Australia

11.5.1 Lung Cancer Screening Market
11.5.2 Lung Cancer Screening Numbers
11.5.3 Lung Cancer Cases
11.5.4 Lung Cancer Deaths


12. Latin America – Lung Cancer Statistics

12.1 Brazil

12.1.1 Lung Cancer Screening Market
12.1.2 Lung Cancer Screening Numbers
12.1.3 Lung Cancer Cases
12.1.4 Lung Cancer Deaths

12.2 Argentina

12.2.1 Lung Cancer Screening Market
12.2.2 Lung Cancer Screening Numbers
12.2.3 Lung Cancer Cases
12.2.4 Lung Cancer Deaths


13. Middle East & Africa – Lung Cancer Statistics

13.1 Saudi Arabia

13.1.1 Lung Cancer Screening Market
13.1.2 Lung Cancer Screening Numbers
13.1.3 Lung Cancer Cases
13.1.4 Lung Cancer Deaths

13.2 U.A.E

13.2.1 Lung Cancer Screening Market
13.2.2 Lung Cancer Screening Numbers
13.2.3 Lung Cancer Cases
13.2.4 Lung Cancer Deaths

13.3 South Africa

13.3.1 Lung Cancer Screening Market
13.3.2 Lung Cancer Screening Numbers
13.3.3 Lung Cancer Cases
13.3.4 Lung Cancer Deaths


14. Porter’s Five Forces

14.1 Bargaining Power of Buyers
14.2 Bargaining Power of Suppliers
14.3 Degree of Rivalry
14.4 Threat of New Entrants
14.5 Threat of Substitutes


15. SWOT Analysis

15.1 Strength
15.2 Weakness
15.3 Opportunity
15.4 Threat


16. Company Analysis

16.1 llumina, Inc.

16.1.1 Overview
16.1.2 Recent Development
16.1.3 Revenue

16.2 Abbott Laboratories

16.2.1 Overview
16.2.2 Recent Development
16.2.3 Revenue

16.3 Thermo Fisher Scientific, Inc

16.3.1 Overview
16.3.2 Recent Development
16.3.3 Revenue

16.4 QIAGEN N.V.

16.4.1 Overview
16.4.2 Recent Development
16.4.3 Revenue

16.5 Roche Holding AG.

16.5.1 Overview
16.5.2 Recent Development
16.5.3 Revenue

16.6 Medtronic plc

16.6.1 Overview
16.6.2 Recent Development
16.6.3 Revenues



List of Figures

Figure-01: Global Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-02: Forecast for – Global Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-03: Global Lung Cancer Screening Volume (Thousand), 2018 – 2022
Figure-04: Forecast for – Global Lung Cancer Screening Volume (Thousand), 2023 – 2028
Figure-05: Cancer Type – Non-Small-cell Lung Cancer (NSCLC) Market (Million US$), 2018 – 2022
Figure-06: Cancer Type – Forecast for Non-Small-cell Lung Cancer (NSCLC) Market (Million US$), 2023 – 2028
Figure-07: Cancer Type – Small-cell Lung Cancer Market (Million US$), 2018 – 2022
Figure-08: Cancer Type – Forecast for Small-cell Lung Cancer Market (Million US$), 2023 – 2028
Figure-09: End Users – Hospitals & Clinics Market (Million US$), 2018 – 2022
Figure-10: End Users – Forecast for Hospitals & Clinics Market (Million US$), 2023 – 2028
Figure-11: End Users – Diagnostic Centers Market (Million US$), 2018 – 2022
Figure-12: End Users – Forecast for Diagnostic Centers Market (Million US$), 2023 – 2028
Figure-13: End Users – Research Institute Market (Million US$), 2018 – 2022
Figure-14: End Users – Forecast for Research Institute Market (Million US$), 2023 – 2028
Figure-15: End Users – Others Market (Million US$), 2018 – 2022
Figure-16: End Users – Forecast for Others Market (Million US$), 2023 – 2028
Figure-17: United States – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-18: United States – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-19: United States – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-20: United States – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-21: United States – Lung Cancer Cases (Number), 2018 – 2022
Figure-22: United States – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-23: United States – Lung Cancer Deaths (Number), 2018 – 2022
Figure-24: United States – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-25: Canada – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-26: Canada – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-27: Canada – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-28: Canada – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-29: Canada – Lung Cancer Cases (Number), 2018 – 2022
Figure-30: Canada – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-31: Canada – Lung Cancer Deaths (Number), 2018 – 2022
Figure-32: Canada – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-33: Mexico – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-34: Mexico – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-35: Mexico – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-36: Mexico – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-37: Mexico – Lung Cancer Cases (Number), 2018 – 2022
Figure-38: Mexico – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-39: Mexico – Lung Cancer Deaths (Number), 2018 – 2022
Figure-40: Mexico – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-41: Germany – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-42: Germany – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-43: Germany – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-44: Germany – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-45: Germany – Lung Cancer Cases (Number), 2018 – 2022
Figure-46: Germany – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-47: Germany – Lung Cancer Deaths (Number), 2018 – 2021
Figure-48: Germany – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-49: United Kingdom – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-50: United Kingdom – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-51: United Kingdom – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-52: United Kingdom – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-53: United Kingdom – Lung Cancer Cases (Number), 2018 – 2022
Figure-54: United Kingdom – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-55: United Kingdom – Lung Cancer Deaths (Number), 2018 – 2022
Figure-56: United Kingdom – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-57: France – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-58: France – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-59: France – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-60: France – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-61: France – Lung Cancer Cases (Number), 2018 – 2022
Figure-62: France – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-63: France – Lung Cancer Deaths (Number), 2018 – 2022
Figure-64: France – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-65: Italy – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-66: Italy – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-67: Italy – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-68: Italy – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-69: Italy – Lung Cancer Cases (Number), 2018 – 2022
Figure-70: Italy – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-71: Italy – Lung Cancer Deaths (Number), 2018 – 2021
Figure-72: Italy – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-73: Spain – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-74: Spain – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-75: Spain – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-76: Spain – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-77: Spain – Lung Cancer Cases (Number), 2018 – 2022
Figure-78: Spain – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-79: Spain – Lung Cancer Deaths (Number), 2018 – 2022
Figure-80: Spain – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-81: Netherlands – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-82: Netherlands – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-83: Netherlands – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-84: Netherlands – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-85: Netherlands – Lung Cancer Cases (Number), 2018 – 2022
Figure-86: Netherlands – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-87: Netherlands – Lung Cancer Deaths (Number), 2018 – 2022
Figure-88: Netherlands – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-89: Switzerland – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-90: Switzerland – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-91: Switzerland – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-92: Switzerland – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-93: Switzerland – Lung Cancer Cases (Number), 2018 – 2022
Figure-94: Switzerland – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-95: Switzerland – Lung Cancer Deaths (Number), 2018 – 2022
Figure-96: Switzerland – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-97: China – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-98: China – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-99: China – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-100: China – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-101: China – Lung Cancer Cases (Number), 2018 – 2022
Figure-102: China – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-103: China – Lung Cancer Deaths (Number), 2018 – 2022
Figure-104: China – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-105: Japan – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-106: Japan – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-107: Japan – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-108: Japan – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-109: Japan – Lung Cancer Cases (Number), 2018 – 2022
Figure-110: Japan – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-111: Japan – Lung Cancer Deaths (Number), 2018 – 2021
Figure-112: Japan – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-113: India – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-114: India – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-115: India – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-116: India – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-117: India – Lung Cancer Cases (Number), 2018 – 2022
Figure-118: India – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-119: India – Lung Cancer Deaths (Number), 2018 – 2021
Figure-120: India – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-121: South Korea – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-122: South Korea – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-123: South Korea – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-124: South Korea – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-125: South Korea – Lung Cancer Cases (Number), 2018 – 2022
Figure-126: South Korea – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-127: South Korea – Lung Cancer Deaths (Number), 2018 – 2022
Figure-128: South Korea – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-129: Australia – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-130: Australia – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-131: Australia – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-132: Australia – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-133: Australia – Lung Cancer Cases (Number), 2018 – 2022
Figure-134: Australia – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-135: Australia – Lung Cancer Deaths (Number), 2018 – 2021
Figure-136: Australia – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-137: Brazil – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-138: Brazil – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-139: Brazil – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-140: Brazil – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-141: Brazil – Lung Cancer Cases (Number), 2018 – 2022
Figure-142: Brazil – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-143: Brazil – Lung Cancer Deaths (Number), 2018 – 2021
Figure-144: Brazil – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-145: Argentina – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-146: Argentina – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-147: Argentina – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-148: Argentina – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-149: Argentina – Lung Cancer Cases (Number), 2018 – 2022
Figure-150: Argentina – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-151: Argentina – Lung Cancer Deaths (Number), 2018 – 2021
Figure-152: Argentina – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-153: Saudi Arabia – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-154: Saudi Arabia – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-155: Saudi Arabia – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-156: Saudi Arabia – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-157: Saudi Arabia – Lung Cancer Cases (Number), 2018 – 2022
Figure-158: Saudi Arabia – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-159: Saudi Arabia – Lung Cancer Deaths (Number), 2018 – 2021
Figure-160: Saudi Arabia – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-161: U.A.E – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-162: U.A.E – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-163: U.A.E – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-164: U.A.E – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-165: U.A.E – Lung Cancer Cases (Number), 2018 – 2022
Figure-166: U.A.E – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-167: U.A.E – Lung Cancer Deaths (Number), 2018 – 2021
Figure-168: U.A.E – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-169: South Africa – Lung Cancer Screening Market (Million US$), 2018 – 2022
Figure-170: South Africa – Forecast for Lung Cancer Screening Market (Million US$), 2023 – 2028
Figure-171: South Africa – Lung Cancer Screening Numbers (Thousand), 2018 – 2022
Figure-172: South Africa – Forecast for Lung Cancer Screening Numbers (Thousand), 2023 – 2028
Figure-173: South Africa – Lung Cancer Cases (Number), 2018 – 2022
Figure-174: South Africa – Forecast for Lung Cancer Cases (Number), 2023 – 2028
Figure-175: South Africa – Lung Cancer Deaths (Number), 2018 – 2021
Figure-176: South Africa – Forecast for Lung Cancer Deaths (Number), 2023 – 2028
Figure-177: llumina, Inc. – Global Revenue (Million US$), 2018 – 2022
Figure-178: llumina, Inc. – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-179: Abbott Laboratories – Global Revenue (Million US$), 2018 – 2022
Figure-180: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-181: Thermo Fisher Scientific, Inc – Global Revenue (Million US$), 2018 – 2022
Figure-182: Thermo Fisher Scientific, Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-183: QIAGEN N.V. – Global Revenue (Million US$), 2018 – 2022
Figure-184: QIAGEN N.V. – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-185: Roche Holding AG. – Global Revenue (Million US$), 2018 – 2022
Figure-186: Roche Holding AG. – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-187: Medtronic plc – Global Revenue (Million US$), 2018 – 2022
Figure-188: Medtronic plc – Forecast for Global Revenue (Million US$), 2023 – 2028

List of Tables

Table-01: Global – Lung Cancer Screening Market Share by Cancer Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Lung Cancer Screening Market Share by Cancer Type (Percent), 2023 – 2028
Table-03: Global – Lung Cancer Screening Market Share by End User (Percent), 2018 – 2022
Table-04: Global – Forecast for Lung Cancer Screening Market Share by End User (Percent), 2023 – 2028
Table-05: Global – Lung Cancer Screening Market Share by Regions (Percent), 2018 – 2022
Table-06: Global – Forecast for Lung Cancer Screening Market Share by Regions (Percent), 2023 – 2028